Vmax Therapeutics Private Limited - Company Profile

It is a research & development private limited company based in Vidyaranyapura, Karnataka, India, established in 2018.
2018 Vidyaranyapura, Karnataka, India Active
Last Updated:
Access Report
About Vmax Therapeutics Private Limited

Vmax Therapeutics Private Limited, a active private limited company, was established on 05 June 2018 in Vidyaranyapura, Karnataka, India. Engaging in science research within the research & development sector, it holds CIN: U73100KA2018PTC113667. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Formerly known as Vicyclx Labs India Private Limited. Its leadership includes Mahesh Bangalore Nanjundappa (Director), Seegebagi Rudresh Ashok (Director). Past directors included Janardhanrao Sundaresh Babu, Mahesh Bangalore Nanjundappa, Seegebagi Rudresh Ashok. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 21 Thindlu 1St Main, 2Nd Cross Behind Durga Temple, Vidyaranyapura, Karnataka, 560097.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2018PTC113667

  • Registration Number

    113667

  • Incorporation Date

    05 June 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Net Worth -62.61%
  • Total Assets -50.01%
Company report

Vmax Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vmax Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vmax Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahesh Bangalore Nanjundappa Director 15 Apr 2022 Current
Seegebagi Rudresh Ashok Director 15 Apr 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Apr 2022 Past
Pramod Abcsdd Director 18 Sep 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 25 Apr 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vmax Therapeutics.

Vmax Therapeutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 62.61%.

Vmax Therapeutics revenue growth over time
Vmax Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -50.01%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 -62.61%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vmax Therapeutics?

Unlock access to Vmax Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Vmax Therapeutics?

Unlock and access historical data on people associated with Vmax Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vmax Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vmax Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vmax Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Vmax Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Vmax Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.

  • Director Appointment

    Mahesh Bangalore Nanjundappa was appointed as a Director was appointed as a Director on 15 Apr 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Seegebagi Rudresh Ashok was appointed as a Director was appointed as a Director on 15 Apr 2022 & has been associated with this company since 3 years 10 months . was documented.

  • Company Incorporation

    Vmax Therapeutics Private Limited was registered on 05 Jun 2018 with Roc Bangalore & aged 7 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vmax Therapeutics Private Limited?

The CIN of Vmax Therapeutics Private Limited is U73100KA2018PTC113667.

Where is Vmax Therapeutics Private Limited headquartered?

Vmax Therapeutics Private Limited is headquartered at 21 Thindlu 1St Main, 2Nd Cross Behind Durga Temple, Vidyaranyapura, Karnataka, 560097.

When was Vmax Therapeutics Private Limited incorporated?

Vmax Therapeutics Private Limited was incorporated on 05 June 2018.

Who are the current directors of Vmax Therapeutics Private Limited?

The current directors of Vmax Therapeutics Private Limited are

What is the primary industry of Vmax Therapeutics Private Limited?

The primary industry of Vmax Therapeutics Private Limited is Research & Development.

Is Vmax Therapeutics Private Limited a listed company?

Vmax Therapeutics Private Limited is unlisted.

What is the capital structure of Vmax Therapeutics Private Limited?

The authorized capital of Vmax Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available